載入...
Effects of Risperidone and Galantamine treatment on Alzheimer biomarker levels in cerebrospinal fluid
BACKGROUND: Treatment for neuropsychiatric symptoms (NPS) in dementia is insufficient. Antipsychotics and acetylcholinesterase inhibitors are used generating symptomatic improvements in behaviour and cognition, but few studies have investigated their effect on Alzheimer biomarkers in cerebrospinal f...
Na minha lista:
| 發表在: | J Alzheimers Dis |
|---|---|
| Main Authors: | , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2017
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6203339/ https://ncbi.nlm.nih.gov/pubmed/28269767 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3233/JAD-160758 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|